Cornell scientists have engineered E. coli to act as a sensitive biosensor for monitoring environmental arsenic, a toxic pollutant most notably found in rice paddies in Southeast Asia. Their new study ...
Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
Cornell scientists have engineered E. coli to act as a sensitive biosensor for monitoring environmental arsenic, a toxic pollutant most notably found ...
Some bacteria do not defeat antibiotics by evolving resistance right away—they outlast treatment by slipping into ...
As antibiotic resistance continues to rise worldwide, scientists are searching for new strategies to combat infections. This ...
Technique that inserts the genome of one bacterial species into the ‘dead’ cells of another could open doors for synthetic ...
Scientists have engineered probiotic bacteria to act as tumor-seeking drug factories. In mice, these bacteria infiltrated tumors and produced a cancer-fighting drug right where it was needed. This ...
Every minute, nearly 500 antibiotic prescriptions are written in the U.S. Many of these drugs succeed, but more are being ...
Researchers have created the first living synthetic bacterium made from non-living parts by killing a bacterial cell and then transplanting the genome of another species into it, blurring the boundary ...
Bacteriophages, viruses that specifically infect bacteria, have emerged as significant influencers in the field of microbial fermentation. Their presence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results